Not a good buy right now: the chart remains structurally bearish (SMA_200 > SMA_20 > SMA_5) with MACD still below zero.
The only clear positive is heavy insider buying (+119.16% last month), but it’s not yet confirmed by trend reversal or improving fundamentals.
With earnings on 2026-02-18 (after hours) and weak recent YoY growth trends, risk/reward is not attractive for an impatient buyer at current levels (~9.42).
Technical Analysis
Trend: Bearish (SMA_200 > SMA_20 > SMA_5), suggesting rallies may be sold until the stack improves.
Momentum: MACD histogram -0.181 (below 0) but negatively contracting → downside momentum is easing, not reversed.
RSI (6): 45.66 (neutral) → no oversold bounce signal.
Pattern-based odds: modeled path is mildly positive (70% chance of ~+0.94% next day, +2.66% next week, +1.76% next month), but this conflicts with the still-bearish moving-average structure.
Insiders are Buying: buying amount increased +119.16% over the last month (bullish sentiment signal).
Market-relative strength today: stock +4.94% while S&P 500 is -1.19% (short-term relative outperformance).
Upcoming earnings (2026-02-18 after hours) could act as an event catalyst if results/forward commentary improve.
Neutral/Negative Catalysts
and MACD is still below zero.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 12.27M, down -20.57% YoY (weak top-line trend).
Net income: 35.75M, down -203.69% YoY (large YoY deterioration as reported).
EPS: 13.6, down -200.59% YoY (material YoY decline as reported).
Gross margin: 30.16, down -4.07% YoY (margin compression).
Overall: reported growth trends are negative, which makes it harder to justify buying into a still-bearish chart.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, suggesting limited/absent recent Wall Street coverage in this dataset.
Wall Street pro view (from available data):
Pros: insider accumulation could imply perceived undervaluation.
Cons: weak YoY fundamentals and bearish trend reduce conviction without a clear catalyst or reversal signal.
Politicians/congress: No recent congress trading data available (last 90 days).
Wall Street analysts forecast NYC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NYC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
